Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand ...

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Global Insulin Pumps Market ...

Insulet has shown impressive revenue and profit growth, driven by its Omnipod System and expanding global presence. Read more ...

The global insulin pumps market, valued at USD 5.5 billion in 2022, is poised for remarkable growth, with an anticipated compound annual growth rate (CAGR) of 10.3% from 2022 to 2032, according to a ...

ACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, is proud to ...

The company's Omnipod 5 device is the first system to ... Insulet is addressing investor concerns over possible impacts on its insulin pump sales due to the surging demand for the latest diabetes ...

The Massachusetts-based company's 'hybrid closed-loop insulin pump', the Omnipod Horizon, demonstrated effective blood glucose control and safety in a 36-hour study involving 24 type 1 diabetes ...

In earnings calls, diabetes tech companies had less to say about tariffs and focused more on future growth.

Investors flocked to shares of NRG as the energy supplier boosted capacity. UnitedHealth stock slumped, and the company’s CEO ...

The systems combine pumps and glucose monitors to automatically adjust insulin delivery based on blood glucose levels. Insulet received an expanded indication last summer for its Omnipod 5 pump to be ...